Related Experiment Video

Updated: Jun 20, 2026

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
08:52

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

Recent advances in tumor vasculature targeting using liposomal drug delivery systems

Amr S Abu Lila1, Tatsuhiro Ishida, Hiroshi Kiwada

  • 1The University of Tokushima, Institute of Health Biosciences, Department of Pharmacokinetics and Biopharmaceutics, 770-8505, Japan.

Expert Opinion on Drug Delivery
|September 29, 2009
PubMed

Insights

Liposomal anticancer drugs target unique tumor vasculature for enhanced efficacy and reduced toxicity. Cationic liposomes show promise for efficient vascular targeting in cancer therapy.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Tumor vasculature exhibits unique physiological characteristics.
  • Targeting liposomal anticancer drugs to tumor vasculature improves therapeutic efficacy and reduces host toxicity.
  • Conventional cancer treatments often have significant side effects.

Purpose of the Study:

  • To review recent advances in liposomal targeting of tumor vasculature.
  • To discuss new approaches for designing and optimizing liposomal delivery systems.
  • To highlight the potential of cationic liposomes for vascular targeting.

Main Methods:

  • Review of current literature on liposomal drug delivery systems.
  • Analysis of strategies for vascular and tumor targeting.
  • Discussion of cationic liposomes as drug carriers.

Main Results:

  • Liposomal drug delivery offers improved therapeutic outcomes.
  • Cationic liposomes are effective carriers for vascular targeting.
  • Dual targeting (vascular and tumor) strategies are being explored.

Conclusions:

  • Liposomal drug delivery to tumor vasculature is a promising strategy for cancer treatment.
  • Cationic liposomes represent a significant advancement in targeted drug delivery.
  • Further research into dual and vascular targeting approaches can optimize cancer therapy.

More Related Videos

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...